Who Owns CANF?

Can-Fite BioPharma Ltd. — Institutional Ownership & 13F Holdings

$2.92

+0.03 (+1.03%)

Market Cap

$2.2M

Shares Outstanding

853,645

Institutional Holders

14

Total Inst. Value

$192K

% of Float Held

QoQ Holder Change

+5

Institutional data as of Q1 2025

New Positions

6

Closed Positions

5

Increased

2

Decreased

2

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1RHUMBLINE ADVISERS$57K38,268
2MORGAN STANLEY$34K23,212
3BNP PARIBAS FINANCIAL MARKETS$33K22,585
4XTX Topco LtdNew$23K15,271
5Virtu Financial LLCNew$20K13,740
6CAPTRUST FINANCIAL ADVISORSNew$16K10,634
7FIFTH THIRD BANCORP$4K3,000
8WELLS FARGO & COMPANY/MN$4K2,700
9Costello Asset Management, INCNew$1K1,000
10Activest Wealth ManagementNew$296200

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
RHUMBLINE ADVISERS+11K$57K
XTX Topco LtdNew+15K$23K
Virtu Financial LLCNew+14K$20K
CAPTRUST FINANCIAL ADVISORSNew+11K$16K
WELLS FARGO & COMPANY/MN+200$4K

Top Sellers

FundShares RemovedValue
MORGAN STANLEY-9K$34K
BNP PARIBAS FINANCIAL MARKETS-3K$33K

Related Stocks

Frequently Asked Questions

How many institutional investors hold CANF?

As of Q1 2025, 14 institutional investors report holding CANF (Can-Fite BioPharma Ltd.) in their 13F filings.

Which hedge fund owns the most CANF?

The largest institutional holder of CANF is RHUMBLINE ADVISERS with $57K in shares.

Are institutions buying or selling CANF?

This quarter, 6 institutions opened new positions in CANF and 5 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.